BioSpace News Archive

Syndax Pharmaceuticals, Inc. announced that in connection with the hiring, announced on April 10, 2023, of Neil Gallagher, M.D., Ph.D., as President, Head of Research and Development, Dr. Gallagher received an inducement award to purchase up to 250,000 shares of common stock.

The National Comprehensive Cancer Network® and the NCCN Foundation® announced four winners for the 2023 NCCN Foundation Young Investigator Awards.

Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that over 1,000 cardiac arrhythmia patients have been treated using the Genesis Robotic Magnetic Navigation system.

Alphatec Holdings, Inc. announced today that it will report first quarter financial results on May 4, 2023, after the market close.

The National Kidney Foundation (NKF) will feature a late-breaking plenary session by Travere Therapeutics on the interim analysis of efficacy and safety data from the ongoing Phase 3 PROTECT Study evaluating FILSPARI™ (Sparsentan) in adults with IgA nephropathy (IgAN).

Pocket Naloxone Corp. announced results from a human factors validation study, using the intend-to-market packaging and labeling, demonstrated that laypersons of varied ages and reading comprehension levels and HCPs (healthcare professionals) were successfully able to administer its novel naloxone nasal swab NaxSwab™ in a simulated emergency rescue environment to potentially revive someone from an opioid overdose.

Nucleix will premiere data from its early lung cancer detection discovery platform, the Nucleix EpiCheck® Lung Atlas, at the American Association for Cancer Research (AACR) Annual Event in Orlando, April 14-19.

Using a new approach for studying live embryonic mouse brains at single-cell resolution, researchers have identified an active multi-layer circuit that forms in the cortex during an unexpectedly early stage of development.

Disc Medicine, Inc. (NASDAQ:IRON) announced today it will host a virtual KOL investor event on Tuesday, April 25, 2023, at 1:00 pm ET/ 10:00 am PT to provide an overview of erythropoietic protoporphyria (EPP), a rare, severe disease caused by mutations in the heme biosynthesis pathway.

World Precision Instruments (WPI) is excited to launch the newest member to its EVOM™ family of products, the EVOM™ Auto.